TMDX241220C65000
- 12.18
- -8.86-42.11%
TransMedics Newsroom
This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Needham Downgrades TransMedics(TMDX.US) to Hold Rating
Needham Downgrades TransMedics Gr to Hold, Maintains Price Target to $109
Express News | Transmedics Group Inc : Needham Cuts to Hold From Buy
Jim Cramer on TransMedics Group, Inc. (TMDX): 'I Don't Know How You Can Really Make A Lot Of Money In That Business, Frankly'
Looking Into TransMedics Gr's Recent Short Interest
Oppenheimer Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $125
TransMedics Group (TMDX) Gets a Buy From Oppenheimer
TransMedics Group Is Maintained at Buy by Canaccord Genuity
TransMedics Group Price Target Cut to $104.00/Share From $109.00 by Canaccord Genuity
CCORF Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $104
Jim Cramer Likes Devon Energy, But Calls Another Stock 'Far Superior'
Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $110
Express News | Transmedics Group Inc : Canaccord Genuity Cuts Target Price to $104 From $109
TransMedics to Participate in the Piper Sandler 36th Annual Healthcare Conference
TransMedics Gr Analyst Ratings
TD Cowen Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $120
Positive Growth in TransMedics Group Amid Rising Transplant Volumes and Market Alignment
Piper Sandler Keeps Their Buy Rating on TransMedics Group (TMDX)
TransMedics Group (NASDAQ:TMDX) Seems To Use Debt Quite Sensibly